Clinical utility of gadoxetate disodium-enhanced hepatic MRI for stereotactic body radiotherapy of hepatocellular carcinoma.

MLA

Nakamura, Yuko, et al. “Clinical Utility of Gadoxetate Disodium-Enhanced Hepatic MRI for Stereotactic Body Radiotherapy of Hepatocellular Carcinoma.” Japanese Journal of Radiology, vol. 33, no. 10, Oct. 2015, pp. 627–35. EBSCOhost, https://doi.org/10.1007/s11604-015-0465-7.

APA

Nakamura, Y., Kimura, T., Higaki, T., Honda, Y., Komoto, D., Yamagami, T., Iida, M., Nagata, Y., Honda, Y., Aikata, H., Chayama, K., & Awai, K. (2015). Clinical utility of gadoxetate disodium-enhanced hepatic MRI for stereotactic body radiotherapy of hepatocellular carcinoma. Japanese Journal of Radiology, 33(10), 627–635. https://doi.org/10.1007/s11604-015-0465-7

Chicago

Nakamura, Yuko, Tomoki Kimura, Toru Higaki, Yukiko Honda, Daisuke Komoto, Takuji Yamagami, Makoto Iida, et al. 2015. “Clinical Utility of Gadoxetate Disodium-Enhanced Hepatic MRI for Stereotactic Body Radiotherapy of Hepatocellular Carcinoma.” Japanese Journal of Radiology 33 (10): 627–35. doi:10.1007/s11604-015-0465-7.